Patent directory · USPTO A61K / A61P
Patents matching “The Regents of the University of California”
3,494 pharma patents match "The Regents of the University of California" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 3,494 pharmaceutical patents matching "The Regents of the University of California" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 10233463
Neurotensin-induced tumor formation is regulated by micro RNA 133A-aftiphilin-dependent receptor recycling
granted -
US 10231998
Method for chemoselection
granted -
US 10227290
Glycosphingolipids for use in modulating immune responses
granted -
US 10227611
Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
granted -
US 10226452
Benzoxazolone derivatives as acid ceramidase inhibitors, and their use as medicaments
granted -
US 10227565
Generating hepatocytes
granted -
US 10227630
Antimicrobial agents from microbial genomes
granted -
US 10221223
Methods and compositions for treating neurodegenerative disorders and alzheimer's disease and improving normal memory
granted -
US 10220117
Methods of mammalian retinal stem cell production and applications
granted -
US 10220022
Compositions and methods employing Wolbachia FtsZ as a target for Albendazole sulfone
granted -
US 10220004
Method of controlled delivery using sub-micron-scale machines
granted -
US 10214566
Mutant adeno-associated virus virions and methods of use thereof
granted -
US 10214522
Anti-alphavbeta1 integrin inhibitors and methods of use
granted -
US 10213430
Nucleotide analogs
granted -
US 10214785
Adeno-associated virus virions with variant capsid and methods of use thereof
granted -
US 10206921
Methods and compositions for treating a subject for central nervous system (CNS) injury
granted -
US 10206953
Ameliorating nervous systems disorders
granted -
US 10208103
Use of HDL-related molecules to treat and prevent proinflammatory conditions
granted -
US 10202584
Red-shifted luciferase-luciferin pairs for enhanced bioluminescence
granted -
US 10202428
Compositions and methods for the delivery of oxygen
granted -
US 10201282
Genetically encoded infrared fluorescent protease reporters
granted -
US 10201597
Codon-optimized lentiviral vector for stem cell reprogramming
granted -
US 10201603
Therapeutic compositions and methods for treating HIV including identification and manipulation of particular domains associated with immunogenicity
granted -
US 10202618
Method of treating type I diabetes using an AAV vector encoding uracortin 2
granted